Organigram Global Inc. (OGI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Organigram Global Inc.

    NASDAQ: OGI · Real-Time Price · USD
    1.63
    0.02 (1.24%)
    At close: Sep 05, 2025, 11:38 AM

    Organigram Global Income Statement

    Financials in CAD. Fiscal year is September - August.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Aug 31, 2022 Aug 31, 2021
    Revenue
    		 159.84M 149.21M 145.81M 79.16M
    Cost of Revenue
    		 112.32M 114.13M 114.24M 107.56M
    Gross Profit
    		 47.52M 35.07M 31.57M -28.4M
    Operating Income
    		 -35.67M -242.74M -43.15M -91.82M
    Interest Income
    		 n/a 3.69M 1.49M 854K
    Pretax Income
    		 -45.44M -233M -14.37M -130.7M
    Net Income
    		 -45.44M -229.48M -14.28M -130.7M
    Selling & General & Admin
    		 68.14M 71.68M 59.21M 46.47M
    Research & Development
    		 11.2M 12.19M 5.96M 3.45M
    Other Expenses
    		 3.85M 193.95M 5.14M -5.53M
    Operating Expenses
    		 83.19M 271.48M 74.72M 63.42M
    Interest Expense
    		 n/a 277.85K 429K 2.96M
    Selling & Marketing Expenses
    		 19.85M 17.86M 16.86M 15.81M
    Cost & Expenses
    		 195.51M 385.61M 188.96M 170.98M
    Income Tax Expense
    		 n/a 3.52M -88K n/a
    Shares Outstanding (Basic)
    		 95.29M 81.29M 80.01M 64.03M
    Shares Outstanding (Diluted)
    		 95.29M 81.29M 85.3M 64.03M
    EPS (Basic)
    		 -0.48 -2.82 -0.18 -2.04
    EPS (Diluted)
    		 -0.48 -2.82 -0.18 -2.04
    EBITDA
    		 -23.59M -25.36M 10.96M -96.71M
    EBIT
    		 -35.67M -48.79M -13.94M -127.74M
    Depreciation & Amortization
    		 12.08M 23.43M 24.91M 31.03M

    Add to Watchlist